Ben Willcox is Professor of Molecular Immunology based at the School of Cancer Sciences.Ben leads an active research group in the field of cancer immunology and immunotherapy, with a focus on understanding immune receptor recognition. His recent work focuses on novel tumour antigens and unconventional T cell function, particularly in immunosurveillance of cellular stress. He has received major grants from Cancer Research UK, the Medical Research Council, the Biotechnology and Biological Sciences Research Council, and most recently the Wellcome Trust.In addition, Ben is director of the University's Cancer Immunology and Immunotherapy Centre (CIIC), a collaborative grouping of over 30 academic and clinical groups focussed on understanding fundamental aspects of tumour immunology and applying these to the development of novel cancer immunotherapy strategies. Check out the CIIC website on http://www.ciic.org.ukBen is also scientific director of the Birmingham Protein Expression Facility, a component of the University's Technology Hub that supports a diverse range of biomedical research by providing high quality protein expression services. He is also a member of the Birmingham Structural Biology Consortium, a cross-college grouping of structural biology research teams.